Armstrong Advisory Group’s Edwards Lifesciences EW Stock Holding History

Armstrong Advisory Group’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$131K	Hold	1,518	–	–	0.01%	310
2026 Q2	$137K	Buy	1,518 +508	+50%	+$42.6K	0.01%	310
2026 Q1	$80.9K	Buy	+1,010	New	+$83.3K	0.01%	348
2024 Q3	–	Sell	-42	Closed	-$3.88K	–	804
2024 Q2	$3.88K	Sell	42 -72	-63%	-$6.38K	﹤0.01%	671
2024 Q1	$8.69K	Hold	114	–	–	﹤0.01%	584
2023 Q4	$8.69K	Hold	114	–	–	﹤0.01%	584
2023 Q3	$7.9K	Hold	114	–	–	﹤0.01%	640
2023 Q2	$10.8K	Hold	114	–	–	﹤0.01%	574
2023 Q1	$9.43K	Hold	114	–	–	﹤0.01%	583
2022 Q4	$8.51K	Buy	+114	New	+$8.79K	﹤0.01%	608

Other funds holding EW

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Ninety One North America New York $2.13B AUM 8.8% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Armstrong Advisory Group's EW Position: Q3 2026 in Review

Armstrong Advisory Group held its Edwards Lifesciences (EW) position steady in Q3 2026 at 1,518 shares worth $131K. The position accounts for 0.01% of the portfolio, ranked #310.

Armstrong Advisory Group first reported a position in EW in Q4 2022 and has held it in 10 quarters since. The position peaked at $137K in Q2 2026. 326 funds tracked by Wall St. Rank hold EW as of Q3 2026.

Armstrong Advisory Group held 1,518 shares of Edwards Lifesciences worth $131K as of Q3 2026.
Armstrong Advisory Group left its Edwards Lifesciences share count unchanged in Q3 2026.
Edwards Lifesciences made up 0.01% of Armstrong Advisory Group's portfolio in Q3 2026, its #310 holding.
Armstrong Advisory Group first reported a position in Edwards Lifesciences in Q4 2022 and has held it in 10 quarters since.
Armstrong Advisory Group's Edwards Lifesciences position peaked at $137K in Q2 2026.
326 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.